Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
B Ljungberg, I Nilsson-Ehle

Abstract

The pharmacokinetics of ciprofloxacin was studied after single intravenous and oral doses of 250 mg and during and after a five-day oral regimen of 500 mg twice daily in eight young (22-34 years) and eight elderly (63-76 years), healthy male volunteers. The absolute bioavailability of an oral dose was greater in the elderly than in the young subjects at both 250 mg (72 versus 58%; p less than 0.05) and 500 mg (79 versus 63%; p less than 0.05). Distribution was unaffected by age. The physiological aging of the kidneys resulted in a reduced renal clearance, while no significant changes in non-renal clearance, total clearance and terminal half-life were found in the elderly. The age-related increase in the bioavailability of ciprofloxacin, whether due to facilitated absorption and/or reduced first-pass elimination, is a hitherto unique finding for antibiotics. As a consequence, reduction of orally administered doses of ciprofloxacin should be considered for elderly patients.

References

Mar 1, 1986·Pharmacotherapy·M LeBelF Vallée
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·T BerganS B Thorsteinsson
Mar 1, 1986·Antimicrobial Agents and Chemotherapy·M LeBelM G Bergeron
Apr 1, 1986·European Journal of Clinical Microbiology·K BornerD Reinitz
Apr 1, 1986·European Journal of Clinical Microbiology·T BerganS Johnsen
May 1, 1986·The Journal of Antimicrobial Chemotherapy·A P BallJ V Willis
Mar 1, 1985·Antimicrobial Agents and Chemotherapy·G HöffkenP Koeppe
Mar 1, 1987·Reviews of Infectious Diseases·B Ljungberg, I Nilsson-Ehle
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·K I PlaisanceH C Standiford
Jan 1, 1987·Respiration; International Review of Thoracic Diseases·A BayerJ Pathy
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·G L DrusanoJ Caldwell
Apr 1, 1983·European Journal of Clinical Microbiology·A Bauernfeind, C Petermüller
Sep 1, 1984·Clinical Pharmacology and Therapeutics·G E AronoffS T Pottratz
Aug 1, 1984·European Journal of Clinical Microbiology·W WingenderP Schacht
Oct 1, 1981·Scandinavian Journal of Clinical and Laboratory Investigation·G Granerus, M Aurell

❮ Previous
Next ❯

Citations

Jul 1, 1993·International Journal of Antimicrobial Agents·E Ludwig
Dec 12, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L C M DorneA G Renwick
Nov 1, 1992·Antimicrobial Agents and Chemotherapy·B A ChristenssonB Strandvik
Dec 30, 1991·The American Journal of Medicine·G R Granneman, D R Guay
May 21, 2005·The American Journal of Geriatric Pharmacotherapy·Barry J Cusack
Jan 1, 1990·Scandinavian Journal of Infectious Diseases. Supplementum
Dec 18, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sindhuja SelvakumarMurali Subramanian
Aug 7, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Fredrik H KarlssonSheila Annie Peters
Jan 10, 2018·Antimicrobial Agents and Chemotherapy·Geoffrey W BirrellMichael D Edstein
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm
Oct 4, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.